Format

Send to

Choose Destination
Neuromodulation. 2019 Jul 16. doi: 10.1111/ner.13020. [Epub ahead of print]

Effectiveness of Neurostimulation Technologies for the Management of Chronic Pain: A Systematic Review.

Author information

1
The Department of Community Health Sciences, University of Calgary, Teaching Research and Wellness Building, Calgary, Alberta, Canada.
2
O'Brien Institute for Public Health, Teaching Research and Wellness Building, Calgary, Alberta, Canada.
3
Research and Innovation Division, British Columbia Ministry of Health, Victoria, British Columbia, Canada.
4
Health Sciences Library, University of Calgary, Calgary, Alberta, Canada.

Abstract

OBJECTIVES:

To describe the state of the literature for clinical effectiveness of neurostimulation used for the management of chronic pain.

METHODS:

A systematic review of spinal cord stimulation (SCS), peripheral nerve stimulation (PNS), peripheral nerve field stimulation (PNFS), and supraorbital transcutaneous electrical nerve stimulation in patients with cancer and noncancer chronic pain was conducted. MEDLINE, Embase, CINAHL, and the Cochrane CENTRAL Register of Controlled Trials were searched, using terms like "electrical stimulation therapy" and "pain management." Direction of effect, consistency across studies, and strength of evidence for effects of neurostimulation on chronic pain were narratively synthesized.

RESULTS:

A total of 15 randomized controlled trials (RCTs) examining SCS, 7 RCTs examining PNS/PNFS, and 1 nonrandomized trial examining supraorbital transcutaneous electrical nerve stimulation (TENS) were included. In nine SCS studies, neurostimulation had positive effects on pain. In three studies, neurostimulation did not significantly reduce pain. For PNS/PNFS, five studies found improvements in pain offered by neurostimulation; pain outcomes were not reported in two studies. In the TENS study, neurostimulation reduced headaches per month and medication consumption. Overall, 21 studies were of low or unclear risk of bias, 4 were high risk of bias, and the TENS study was not appropriate for assessment using the Cochrane Risk of Bias tool.

CONCLUSIONS:

A robust body of evidence examining SCS and PNS was identified. Only one study for PNFS and TENS was identified; both reported pain reductions. Generally, neurostimulation improved pain control. Future studies should examine the effectiveness of neurostimulation offered early in the trajectory of chronic pain.

KEYWORDS:

Chronic pain; implantable neurostimulators; peripheral nerves; spinal cord stimulation; transcutaneous electrical nerve stimulation

PMID:
31310417
DOI:
10.1111/ner.13020

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center